Reference
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova,
A., Bork, P., . . . Sunyaev, S. R. (2010). A method and server for
predicting damaging missense mutations. Nature methods, 7 (4),
248-249.
Baban, A., Postma, A. V., Marini, M., Trocchio, G., Santilli, A.,
Pelegrini, M., . . . Barnett, P. (2014). Identification of TBX5
mutations in a series of 94 patients with Tetralogy of Fallot.American Journal of Medical Genetics Part A, 164 (12), 3100-3107.
Basson, C. T., Huang, T., Lin, R. C., Bachinsky, D. R., Weremowicz, S.,
Vaglio, A., . . . Romeo, G. (1999). Different TBX5 interactions in heart
and limb defined by Holt–Oram syndrome mutations. Proceedings of
the National Academy of Sciences, 96 (6), 2919-2924.
Bhatt, A. B., Foster, E., Kuehl, K., Alpert, J., Brabeck, S., Crumb, S.,
. . . Karamlou, T. (2015). Congenital heart disease in the older adult.Circulation, 131 (21), 1884-1931.
Bonachea, E. M., Zender, G., White, P., Corsmeier, D., Newsom, D.,
Fitzgerald-Butt, S., . . . McBride, K. L. (2014). Use of a targeted,
combinatorial next-generation sequencing approach for the study of
bicuspid aortic valve. BMC medical genomics, 7 (1), 56.
Boogerd, C. J., Dooijes, D., Ilgun, A., Hordijk, R., Van De Laar, I. M.,
Rump, P., . . . Postma, A. V. (2010). Functional analysis of novel TBX5
T-box mutations associated with Holt-Oram syndrome. Cardiovascular
research , cvq178.
Brassington, A.-M. E., Sung, S. S., Toydemir, R. M., Le, T., Roeder, A.
D., Rutherford, A. E., . . . Bamshad, M. J. (2003). Expressivity of
Holt-Oram syndrome is not predicted by TBX5 genotype. The American
Journal of Human Genetics, 73 (1), 74-85.
Brown, D. D., Martz, S. N., Binder, O., Goetz, S. C., Price, B. M.,
Smith, J. C., & Conlon, F. L. (2005). Tbx5 and Tbx20 act
synergistically to control vertebrate heart morphogenesis.Development, 132 (3), 553-563.
Capriotti, E., Calabrese, R., & Casadio, R. (2006). Predicting the
insurgence of human genetic diseases associated to single point protein
mutations with support vector machines and evolutionary information.Bioinformatics, 22 (22), 2729-2734.
Cheng, J., Randall, A., & Baldi, P. (2006). Prediction of protein
stability changes for single‐site mutations using support vector
machines. Proteins: Structure, Function, and Bioinformatics,
62 (4), 1125-1132.
Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005).
SCRATCH: a protein structure and structural feature prediction server.Nucleic acids research, 33 (suppl 2), W72-W76.
Chung, I.-M., & Rajakumar, G. (2016). Genetics of congenital heart
defects: the NKX2-5 gene, a key player. Genes, 7 (2), 6.
Cross, S. J., Ching, Y.-h., Li, Q. Y., Armstrong-buisseret, L.,
Spranger, S., Lyonnet, S., . . . Leheup, B. (2000). The mutation
spectrum in Holt-Oram syndrome. Journal of medical genetics,
37 (10), 785-787.
Dreßen, M., Lahm, H., Lahm, A., Wolf, K., Doppler, S., Deutsch, M. A., .
. . Ewert, P. (2016). A novel de novo TBX5 mutation in a patient with
Holt–Oram syndrome leading to a dramatically reduced biological
function. Molecular Genetics & Genomic Medicine, 4 (5), 557-567.
Fahed, A. C., Gelb, B. D., Seidman, J., & Seidman, C. E. (2013).
Genetics of Congenital Heart Disease. Circulation research,
112 (4), 707-720.
Fan, C., Duhagon, M., Oberti, C., Chen, S., Hiroi, Y., Komuro, I., . . .
Wang, Q. (2003). Novel TBX5 mutations and molecular mechanism for
Holt-Oram syndrome. Journal of medical genetics, 40 (3), e29-e29.
Fujita, J., Freire, P., Coarfa, C., Benham, A. L., Gunaratne, P.,
Schneider, M. D., . . . Zwaka, T. P. (2017). Ronin Governs Early Heart
Development by Controlling Core Gene Expression Programs. Cell
Reports, 21 (6), 1562-1573.
Ghosh, T. K., Packham, E. A., Bonser, A. J., Robinson, T. E., Cross, S.
J., & Brook, J. D. (2001). Characterization of the TBX5 binding site
and analysis of mutations that cause Holt–Oram syndrome. Human
molecular genetics, 10 (18), 1983-1994.
Gittenberger-de Groot, A. C., Calkoen, E. E., Poelmann, R. E.,
Bartelings, M. M., & Jongbloed, M. R. (2014). Morphogenesis and
molecular considerations on congenital cardiac septal defects.Annals of medicine, 46 (8), 640-652.
Granados‐Riveron, J. T., Pope, M., Bu’Lock, F. A., Thornborough, C.,
Eason, J., Setchfield, K., . . . Feneley, M. P. (2012). Combined
Mutation Screening of NKX2‐5, GATA4, and TBX5 in Congenital Heart
Disease: Multiple Heterozygosity and Novel Mutations. Congenital
heart disease, 7 (2), 151-159.
Guo, D. F., Li, R. G., Yuan, F., Shi, H. Y., Hou, X. M., Qu, X. K., . .
. Jiang, J. Q. (2016). TBX5 loss-of-function mutation contributes to
atrial fibrillation and atypical Holt-Oram syndrome. Molecular
medicine reports, 13 (5), 4349-4356.
Hoffman, J. I., & Kaplan, S. (2002). The incidence of congenital heart
disease. Journal of the American college of cardiology, 39 (12),
1890-1900.
Lin, C.-J., Lin, C.-Y., Chen, C.-H., Zhou, B., & Chang, C.-P. (2012).
Partitioning the heart: mechanisms of cardiac septation and valve
development. Development, 139 (18), 3277-3299.
Liu, C. F., Brandt, G. S., Hoang, Q. Q., Naumova, N., Lazarevic, V.,
Hwang, E. S., . . . Petsko, G. A. (2016). Crystal structure of the DNA
binding domain of the transcription factor T-bet suggests simultaneous
recognition of distant genome sites. Proceedings of the National
Academy of Sciences, 113 (43), E6572-E6581.
Ma, J.-F., Yang, F., Mahida, S. N., Zhao, L., Chen, X., Zhang, M. L., .
. . Zheng, G.-Y. (2016). TBX5 mutations contribute to early-onset atrial
fibrillation in Chinese and Caucasians. Cardiovascular research,
109 (3), 442-450.
McDermott, D. A., Bressan, M. C., He, J., Lee, J. S., Aftimos, S.,
Brueckner, M., . . . Innis, J. W. (2005). TBX5 genetic testing validates
strict clinical criteria for Holt-Oram syndrome. Pediatric
research, 58 (5), 981-986.
Nimura, K., & Kaneda, Y. (2016). Elucidating the mechanisms of
transcription regulation during heart development by next-generation
sequencing. Journal of human genetics, 61 (1), 5-12.
Plekhanova, E., Nuzhdin, S. V., Utkin, L. V., & Samsonova, M. G.
(2019). Prediction of deleterious mutations in coding regions of mammals
with transfer learning. Evolutionary applications, 12 (1), 18-28.
Postma, A. V., van de Meerakker, J. B., Mathijssen, I. B., Barnett, P.,
Christoffels, V. M., Ilgun, A., . . . Moorman, A. F. (2008). A
gain-of-function TBX5 mutation is associated with atypical Holt–Oram
syndrome and paroxysmal atrial fibrillation. Circulation research,
102 (11), 1433-1442.
Rodrigues, C. H., Pires, D. E., & Ascher, D. B. (2018). DynaMut:
predicting the impact of mutations on protein conformation, flexibility
and stability. Nucleic acids research, 46 (W1), W350-W355.
Soheili, F., Darabi, P., Dahmardeh, F., Heidary, N., Jalili, Z.,
Fooladi, S., & Saeid, M. (2015). Nkx2-5 Mutations in Patients with
Non-Syndrome Congenital Heart Disease.
Soheili, F., Jalili, Z., Rahbar, M., Khatooni, Z., Mashayekhi, A., &
Jafari, H. (2018). Novel mutation of GATA4 gene in Kurdish population of
Iran with nonsyndromic congenital heart septals defects.Congenital Heart Disease . doi:10.1111/chd.12571
Stirnimann, C. U., Ptchelkine, D., Grimm, C., & Müller, C. W. (2010).
Structural Basis of TBX5–DNA Recognition: The T-Box Domain in Its
DNA-Bound and-Unbound Form. Journal of molecular biology, 400 (1),
71-81.
van Weerd, J. H., & Christoffels, V. M. (2016). The formation and
function of the cardiac conduction system. Development, 143 (2),
197-210.
Wang, Z.-C., Ji, W.-H., Ruan, C.-W., Liu, X.-Y., Qiu, X.-B., Yuan, F., .
. . Huang, R.-T. (2016). Prevalence and Spectrum of TBX5 Mutation in
Patients with Lone Atrial Fibrillation. International journal of
medical sciences, 13 (1), 60.
Yoshida, A., Morisaki, H., Nakaji, M., Kitano, M., Kim, K.-s., Sagawa,
K., . . . Kato, H. (2015). Genetic mutation analysis in Japanese
patients with non-syndromic congenital heart disease. Journal of
human genetics .
Zhou, W., Zhao, L., Jiang, J. Q., Jiang, W. F., Yang, Y. Q., & Qiu, X.
B. (2015). A novel TBX5 loss-of-function mutation associated with
sporadic dilated cardiomyopathy. International journal of
molecular medicine, 36 (1), 282-288.
Zhu, T., Qiao, L., Wang, Q., Mi, R., Chen, J., Lu, Y., . . . Zheng, Q.
(2017). T-box family of transcription factor-TBX5, insights in
development and disease. Am J Transl Res, 9 (2), 442-453.